Taking up Cancer Immunotherapy Challenges: Bispecific Antibodies, the Path Forward?

Author： Del Bano Joanie   Chames Patrick   Baty Daniel   Kerfelec Brigitte  

Publisher： MDPI

E-ISSN： 2073-4468|5|1|1-1

ISSN： 2073-4468

Source： Antibodies, Vol.5, Iss.1, 2015-12, pp. : 1-1

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cancer Immunotherapy by Retargeting of Immune Effector Cells via Recombinant Bispecific Antibody Constructs

By Stamova Slava   Koristka Stefanie   Keil Juliane   Arndt Claudia   Feldmann Anja   Michalk Irene   Bartsch Holger   Bippes Claudia C.   Schmitz Marc   Cartellieri Marc   Bachmann Michael  

Antibodies, Vol. 1, Iss. 2, 2012-07 ,pp. : 172-198

MDPI

Access to resources Recommend Favorite

Human Cell Line-Derived Monoclonal IgA Antibodies for Cancer Immunotherapy

By Hart Felix   Danielczyk Antje   Goletz Steffen  

Bioengineering, Vol. 4, Iss. 2, 2017-05 ,pp. : 42-42

MDPI

Access to resources Recommend Favorite

Improved assembly of bispecific antibodies from knob and hole half‐antibodies

By  

BIOTECHNOLOGY PROGRESS (ELECTRONIC), Vol. 31, Iss. 5, 2015-09 ,pp. : 1315-1322

John Wiley & Sons Inc

Access to resources Recommend Favorite

In Vivo Secretion of Bispecific Antibodies Recruiting Lymphocytic Effector Cells

By Compte Marta   Nuñez-Prado Natalia   Sanz Laura   Alvarez-Vallina Luis  

Antibodies, Vol. 2, Iss. 3, 2013-06 ,pp. : 415-425

MDPI

Access to resources Recommend Favorite

The Development of Bispecific Hexavalent Antibodies as a Novel Class of DOCK-AND-LOCKTM (DNLTM) Complexes

By Chang Chien-Hsing   Rossi Edmund A.   Wang Yang   Cardillo Thomas M.   Goldenberg David M.  

Antibodies, Vol. 2, Iss. 2, 2013-05 ,pp. : 353-370

MDPI

Access to resources Recommend Favorite